Carnelian Capital Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Carnelian capital advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Carnelian Capital Advisors Today - Breaking & Trending Today

pharma: Vikas Khemani explains why big money can be made in pharma

Vikas Khemani of Carnelian Capital Advisors discusses the growth potential of the pharma sector and the positive outlook for IT companies like TCS and Infosys. He believes that the underperformance of pharma over the past seven to eight years is coming to an end, with a promising trend emerging in both the US and domestic markets. Khemani also highlights the long-term investment opportunities in the IT sector, particularly with the decline in US interest rates. ....

Uttar Pradesh , Vikas Khemani , Bajaj Auto , Axis Bank , Tata Motors , Offering College , Carnelian Capital Advisors , Leadership Excellence , Executive Officer , Operations Officer , Product Officer , Senco Gold , Vibrant Gujarat , Might Also Like , Stock Market , It Stocks Outlook , Expert View , Et Now ,

ipo market: Does high IPO excitement mean market is about to peak out? Vikas Khemani answers

“Every company which is going public is not good. In the SME segment, we are seeing absolute crazy subscriptions for companies that have not been around for long, comparing valuation to major companies. In the main board, I am not seeing many euphoric cases yet though it might get there. I am worried about that aspect.” ....

Uttar Pradesh , Vikas Khemani , Offering College , Indian School Of Business , Carnelian Capital Advisors , Leadership Excellence , Operations Officer , Might Also Like , Aditya Birla Financials , Reserve Bank , Ipo Market , Rate Cut , Sme Ipos , Expert View , Stock Market , Et Now ,

bullish sentiment: Why Vikas Khemani has a bullish view in short, medium & long term

“We are very, very positive on the CDMO and CRO space within pharma, which we think is a very structural trend over the next 5 to 10 to 15 years. The CDMO space is a very small space right now. But what we saw in IT, we could see in the CDMO space, specific to pharma.” ....

Uttar Pradesh , Vikas Khimani , Vikas Khemani , Syngene International , Indian School Of Business , Laurus Lab , Offering College , Carnelian Capital Advisors , Leadership Excellence , Executive Officer , Product Officer , Might Also Like , Bullish Sentiment , Market View , Laurus Lab Syngene Newland , Economic Growth , Expert View , Stock Market , Et Now ,